Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy
Paulius Venalis, Ingrid E. Lundberg
Lara D. Veeken (2013) Vol. 53, Iss. 3, pp. 397-405
Closed Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Emerging role of long noncoding RNAs in autoimmune diseases
Guo‐Cui Wu, Hai‐Feng Pan, Rui‐Xue Leng, et al.
Autoimmunity Reviews (2015) Vol. 14, Iss. 9, pp. 798-805
Closed Access | Times Cited: 255
Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors
Alvaro Moreira, Carmen Loquai, Claudia Pföhler, et al.
European Journal of Cancer (2018) Vol. 106, pp. 12-23
Closed Access | Times Cited: 207
Macrophage Plasticity in Skeletal Muscle Repair
Elena Rigamonti, Paola Zordan, Clara Sciorati, et al.
BioMed Research International (2014) Vol. 2014, pp. 1-9
Open Access | Times Cited: 172
Cell death, clearance and immunity in the skeletal muscle
Clara Sciorati, Elena Rigamonti, Angelo A. Manfredi, et al.
Cell Death and Differentiation (2016) Vol. 23, Iss. 6, pp. 927-937
Open Access | Times Cited: 152
Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review
Carlo Mainetti, Benedetta Terziroli Beretta‐Piccoli, Carlo Selmi
Clinical Reviews in Allergy & Immunology (2017) Vol. 53, Iss. 3, pp. 337-356
Closed Access | Times Cited: 121
Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020
Kunyan Sun, Yong Fan, Yunxia Wang, et al.
Seminars in Arthritis and Rheumatism (2020) Vol. 51, Iss. 1, pp. 175-191
Closed Access | Times Cited: 91
Identification of common mechanisms and biomarkers for dermatomyositis and atherosclerosis based on bioinformatics analysis
Yirong Ma, Junyu Lai, Qiang Wan, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 6
Open Access | Times Cited: 7
Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications
E Morán, F.L. Mastaglia
Clinical & Experimental Immunology (2014) Vol. 178, Iss. 3, pp. 405-415
Open Access | Times Cited: 63
Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies
Hidenaga Kawasumi, Takahisa Gono, Yasushi Kawaguchi, et al.
Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine (2015) Vol. 9s1, pp. CCRPM.S23313-CCRPM.S23313
Open Access | Times Cited: 60
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review
Angela Ceribelli, Maria De Santis, Natasa Isailovic, et al.
Clinical Reviews in Allergy & Immunology (2016) Vol. 52, Iss. 1, pp. 58-70
Closed Access | Times Cited: 53
Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis
Dana Mandel, Charles J. Malemud, Ali Askari
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 5, pp. 1084-1084
Open Access | Times Cited: 50
The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases
Liuting Zeng, Xiang Wang, Wei Xiao, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Successful treatment of rheumatoid arthritis complicated by anti-Jo-1 antibody-positive myopathy with abatacept: A case report
Shuhei Yoshida, Jumpei Temmoku, Kenji Saito, et al.
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE (2025)
Open Access
The role of type I interferons and other cytokines in dermatomyositis
Ashish Arshanapalli, Mihir Shah, Vindhya Veerula, et al.
Cytokine (2014) Vol. 73, Iss. 2, pp. 319-325
Closed Access | Times Cited: 47
Rituximab in systemic autoimmune rheumatic diseases: indications and practical use
Nathalie Berghen, Jean‐Baptiste Vulsteke, René Westhovens, et al.
Acta Clinica Belgica (2018) Vol. 74, Iss. 4, pp. 272-279
Closed Access | Times Cited: 40
The Role of Immune Cells in the Pathogenesis of Idiopathic Inflammatory Myopathies
Lijuan Zhao, Qi Wang, Bin Zhou, et al.
Aging and Disease (2021) Vol. 12, Iss. 1, pp. 247-247
Open Access | Times Cited: 27
Increased risk of myocarditis and arrythmias in anti-Ku-positive scleroderma–myositis overlap patients: a case series
Aashik Bhalodia, Kevin Bermea, J. Thomas Schmidt, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 9, pp. e268-e269
Closed Access | Times Cited: 4
Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets
Fabricio Espinosa‐Ortega, Diana Gómez‐Martín, K. Santana-de Anda, et al.
Clinical & Experimental Immunology (2014) Vol. 179, Iss. 3, pp. 520-528
Open Access | Times Cited: 36
Understanding the origin of non-immune cell-mediated weakness in the idiopathic inflammatory myopathies – potential role of ER stress pathways
Adam P. Lightfoot, Kanneboyina Nagaraju, Anne McArdle, et al.
Current Opinion in Rheumatology (2015) Vol. 27, Iss. 6, pp. 580-585
Closed Access | Times Cited: 35
The SNPs of mitochondrial DNA displacement loop region and mitochondrial DNA copy number associated with risk of polymyositis and dermatomyositis
Yufei Zhao, Chenxing Peng, Ruixue Lai, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
A protocol for single nucleus RNA-seq from frozen skeletal muscle
Tyler Soule, Carly Sabine Pontifex, Nicole L. Rosin, et al.
Life Science Alliance (2023) Vol. 6, Iss. 5, pp. e202201806-e202201806
Open Access | Times Cited: 9
B-cell survival factors in autoimmune rheumatic disorders
Sandra A. Morais, Andreia Vilas‐Boas, David Isenberg
Therapeutic Advances in Musculoskeletal Disease (2015) Vol. 7, Iss. 4, pp. 122-151
Open Access | Times Cited: 31
The role of interleukin-17 in immune-mediated inflammatory myopathies and possible therapeutic implications
E Morán, Frank Mastaglia
Neuromuscular Disorders (2014) Vol. 24, Iss. 11, pp. 943-952
Closed Access | Times Cited: 27
Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies
Meredyth Wilkinson, Anna Radziszewska, Chris Wincup, et al.
Lara D. Veeken (2019)
Open Access | Times Cited: 25
KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker
Masanori Hanaoka, Yasuhiro Katsumata, Hidenaga Kawasumi, et al.
Modern Rheumatology (2018) Vol. 29, Iss. 4, pp. 625-632
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top